Company Search:
Advanced Search
Sponsored Links
Targovax ASA Company Snapshot
Targovax ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Targovax ASA with three other miscellaneous service companies in Europe: Oryzon Genomics Sa of Spain (2017 sales of 16,764.00 Euro [US$20,747.46 ] ), Neurovive Pharmaceutical AB of Sweden (27,000.00 Swedish Kronor [US$3,212.73 ] of which 100% was Neurostat), and Immunovia AB (publ) which is also based in Sweden (148,963.00 Swedish Kronor [US$17,725.11 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Targovax ASA
  Stock Performance Chart for Targovax ASA
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 15.90
(Figures in Norwegian Kroner)
1 Week 3.5%   13 Weeks 4.3%  
4 Weeks -14.5%   52 Weeks -27.2%  
Targovax ASA Key Data:
  Ticker: TRVX Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 37,000
(Year Ending Jan 2018).
Employees: 27
  Currency: Norwegian Kroner Market Cap: 836,496,885
  Fiscal Yr Ends: December Shares Outstanding: 52,609,867
  Share Type: Ordinary Closely Held Shares: 9,043,289
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.